Cargando…

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials

BACKGROUND: Alendronate has been used to prevent or treat glucocorticoid-induced osteoporosis (GIO), data regarding its efficacy are inconsistent. We conducted the current systematic review and meta-analysis to evaluate both efficacy and safety of alendronate in the treatment of GIO. METHODS: PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ya-Kang, Zhang, Yu-min, Qin, Si-Qing, Wang, Xu, Ma, Tao, Guo, Jian-Bin, Zhu, Chao, Luo, Zhuo-Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211897/ https://www.ncbi.nlm.nih.gov/pubmed/30334952 http://dx.doi.org/10.1097/MD.0000000000012691

Ejemplares similares

Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials
por: Wang, Ya-Kang, et al.
Publicado: (2017)

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials
por: Liu, Zhi-Ming, et al.
Publicado: (2022)

An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis
por: Liang, Na, et al.
Publicado: (2022)

The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial
por: Iseri, Ken, et al.
Publicado: (2018)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine
por: Ren, Hui, et al.
Publicado: (2017)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis
por: Qin, Ling, et al.
Publicado: (2007)

Sequential treatment of teriparatide and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a prospective study
por: Yang, Dazhi, et al.
Publicado: (2023)

Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
por: Xiong, Zhencheng, et al.
Publicado: (2022)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Synthesis of composite magnetic nanoparticles Fe(3)O(4) with alendronate for osteoporosis treatment
por: Lee, Ming-Song, et al.
Publicado: (2016)

Effect of Low-Magnitude Whole-Body Vibration Combined with Alendronate in Ovariectomized Rats: A Random Controlled Osteoporosis Prevention Study
por: Chen, Guo-Xian, et al.
Publicado: (2014)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
por: Jain, Sumit Kumar, et al.
Publicado: (2011)

Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report
por: Widjaja, David, et al.
Publicado: (2011)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
por: Ahn, Guk Young, et al.
Publicado: (2021)

Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax(®)) for osteoporosis treatment
por: Unnanuntana, Aasis, et al.
Publicado: (2017)

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
por: Li, Mei, et al.
Publicado: (2022)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend
por: Greenspan, Susan L., et al.
Publicado: (2020)

Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model
por: Muraleva, Natalya A., et al.
Publicado: (2012)

A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Iwamoto, Jun, et al.
Publicado: (2008)

Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?
por: Kolios, Leila, et al.
Publicado: (2009)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_knfod3c6u0n8sm2m5p3fn8sd0d